Latest News

The Medicines and Healthcare Products Regulatory Agency (MHRA) granted approval for EURneffy, the first intranasal adrenaline (epinephrine) treatment for emergency management of anaphylaxis, offering a…

Elinzanetant (Lynkuet) finally getting MHRA approval to provide relief for women suffering from menopausal symptoms. With Elinzanetant being the first non-hormonal therapy of its kind,…

The FDA just recently placed investigational measures on Sarepta Therapeutics new medication “Elevidys” that has been indicated for treatment patients suffering from Duchenne muscular dystrophy…

After deep review the EMA’s safety committee (PRAC) has decided on stopping the temporary restriction of people aged 65 years or older from getting the…

On July 2, 2025, the FDA gave accelerated approval to linvoseltamab-gcpt (Lynozyfic, Regeneron Pharmaceuticals, Inc.), a targeted therapy that helps the immune system attack cancer…

The Saudi food & drug authority has been actively working towards advancing public health in kingdom through ongoing strategic initiatives aimed at strengthening the healthcare…

Based on recent FDA findings the use of extended-release stimulants for ADHD management in children below 6 years old has been causing weight loss &…

As of 1st of July 2025 regulations associated with the use of radioactive substances or ionizing radiation has changed to ease the process for applications…

Patients fighting extensive stage small cell lung cancer (SCLC) now have new hope with UK’s Medicines and Healthcare products Regulatory Agency (MHRA) recently approving serplulimab…

The European Medicines Agency (EMA) has suggested granting provisional marketing authorization for Rezdiffra (resmetirom) the first treatment in the EU for noncirrhotic metabolic dysfunction-associated steatohepatitis…

With UK’s continuing efforts in providing better healthcare services & treatments for patients, comes the new initiative of providing at home cervical testing kits to…

On 24 June, the United Kingdom was the first country to join the HealthAI Global Regulatory Network, a new international initiative to ensure the safe and effective use of artificial intelligence (AI)…

Finding a treatment for hematological malignancies can be a challenging as it mainly depends on finding a suitable donor & if they are lucky enough…

Scopolamine transdermal patches were approved by the FDA in the 1970s for managing nausea and vomiting caused by motion sickness; later, they also got FDA…

In a significant advancement for lymphoma treatment, the FDA has approved Monjuvi (tafasitamab-cxix) in combination with lenalidomide and rituximab for adults with relapsed or refractory…